drugset / Trial / NCT06803589
Growth Hormone for the Treatment of Gastroparesis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.
Timeline
- Start
- 2024-10-22
- Primary completion
- 2027-10
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | somapacitan | Protein / enzyme biologic | 1.5 mg | Subcutaneous |